Cytosorbents Corporation
NASDAQ: CTSO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Phillip Chan
- Employees
- 149
- Headquarters
- Princeton, United States
- IPO year
- 2006
- Market cap
- $29.3M
- Website
- https://www.cytosorbents.com
Loading CTSO…
Loading profile data…Frequently asked questions about CTSO
What does Cytosorbents Corporation (CTSO) do?
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology. The company's leading product, CytoSorb, is an extracorporeal filter designed to remove cytokines from the blood....
Where does CTSO trade?
Cytosorbents Corporation (CTSO) trades on the NASDAQ Capital Market.
What sector is CTSO in?
Cytosorbents Corporation (CTSO) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Cytosorbents Corporation?
Phillip Chan is the chief executive officer of Cytosorbents Corporation (CTSO).
Where is Cytosorbents Corporation headquartered?
Cytosorbents Corporation is headquartered in United States.
Does CTSO pay a dividend?
Cytosorbents Corporation (CTSO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CTSO go public?
Cytosorbents Corporation (CTSO) completed its initial public offering in 2006.